EGFR(V)-EDV-Dox
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EGFR(V)-EDV-Dox, covering 2025-06-03 to 2025-06-03. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Immunogenicity of EGFR(V)-EDV-Dox in Subjects With Recurrent GBM [Phase 1]